Aytu Biopharma Inc - ESG Rating & Company Profile powered by AI
Browse to the bottom of the page for potential risks for Aytu Biopharma Inc based on sector, geography and marketcap. Alternative corporations in the rating industry group for Aytu Biopharma Inc are displayed. The ESG rating covers 17 United Nations SDGs including: 'Gender Equality', 'Decent Work & Economic Growth' and 'Partnerships for the Goals'.
Aytu Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 0.0, social score of 1.6 and governance score of 2.0.
1.2
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1755 | TRACON Pharmaceuticals Inc | 1.3 | Low |
| 1755 | Trimurthi Ltd | 1.3 | Low |
| 1779 | Aytu Biopharma Inc | 1.2 | Low |
| 1779 | Cell Biotech Co Ltd | 1.2 | Low |
| 1779 | Aurisco Pharmaceutical Co Ltd | 1.2 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aytu Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aytu Biopharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Aytu Biopharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aytu Biopharma Inc offer flexible work?
Sign up for free to unlockDoes Aytu Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aytu Biopharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aytu Biopharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose water use targets?
Sign up for free to unlockDoes Aytu Biopharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aytu Biopharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aytu Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aytu Biopharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aytu Biopharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aytu Biopharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aytu Biopharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose its waste policy?
Sign up for free to unlockDoes Aytu Biopharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose energy use targets?
Sign up for free to unlockDoes Aytu Biopharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aytu Biopharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aytu Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.